Cortexyme, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Cortexyme, Inc.
CIK #0001662774
EDGAR Form CIK 2011 - 2025
10-K [0001662774]
10-Q [0001662774]
3 [0001662774]
4 [0001662774]
5 [0001662774]
8-K [0001662774]
D [0001662774]
SC 13D [0001662774]
SC 13G [0001662774]
Form 13D/13G Filer Form 13D/13G Subject Filed
Nantahala Capital Management LLC Quince Therapeutics Inc [2025-08-14]
Sofinnova Partners SAS Quince Therapeutics Inc [2025-02-14]
Lamond David Quince Therapeutics Inc [2024-11-13]
Sofinnova Partners SAS Quince Therapeutics Inc [2024-02-12]
Genextra Spa Quince Therapeutics Inc [2023-12-15]
BML Investment Partners LP Quince Therapeutics Inc [2023-07-17]
Tang Capital Partners LP Quince Therapeutics Inc [2023-03-31]
Capital World Investors Cortexyme Inc [2021-02-16]
Capital International Investors Cortexyme Inc [2021-02-16]
Capital International Investors Cortexyme Inc [2021-02-16]
Lamond David Cortexyme Inc [2019-09-30]
Lamond Pierre Cortexyme Inc [2019-09-30]
EPQ LLC CTYM PS Cortexyme Inc [2019-06-10]
Pfizer Inc Cortexyme Inc [2019-05-22]
Takeda Pharmaceutical Co Ltd Cortexyme Inc [2019-05-20]
Form 3/4/5 Subject 2011 - 2025
Hannah Brendan
Quince Therapeutics, Inc.
Ryan Charles S.
Thye Dirk
Lamond David
Senner Christopher J.
Benatti Luca
Ryan UNA S
Patni Rajiv
Bray June
View All
Terms | Privacy | Guide
tony@aum13f.com